Wenlong Xu

Wenlong Xu is an accomplished professional in the field of molecular and synthetic biology, currently serving as the Director of Molecular & Synthetic Biology at Sonata Therapeutics since November 2022, after previously holding the position of Associate Director. Prior to this role, Wenlong Xu worked as a Scientist at Biogen from August 2020 to November 2022 and was a Postdoctoral Associate at the Massachusetts Institute of Technology from December 2018 to August 2020. Wenlong Xu's earlier experience includes serving as a Program Aide at Colorado State University and as a Graduate Research Assistant, where responsibilities included research and development as well as teaching assistance for undergraduate courses. Wenlong Xu holds a Doctor of Chemical Engineering with a focus on Bioengineering from Colorado State University and obtained a Bachelor of Bioengineering from Northwest A&F University.